Welcome to the Dept. of Neuroscience & Regenerative Medicine at the Medical College of Georgia!
The mission of the Department is to promote multidisciplinary research and teaching excellence in both biomedical and clinical sciences.
The department was founded in 1993 as the Institute of Molecular Medicine and Genetics. We seek to attract outstanding faculty and bright students by creating a welcoming, collegial and collaborative environment to foster success and creativity. Our faculty’s research focuses on a variety of fundamental areas, ranging from neurodegenerative and neuropsychiatric disorders, brain injury, learning and memory, neuroprotection, development, inflammation and regenerative medicine, using a broad repertoire of experimental approaches. Our department is also the home to the Transgenic and Genome Editing Core, which is supported by the Georgia Research Alliance.
The Medical College of Georgia is the state's only public medical school. Founded nearly 200 years ago in 1828 as the nation's fifth public medical school, the third medical school in the Southeast and the thirteenth in the nation, the Medical College of Georgia has one of the largest class sizes in the country. The medical school works to optimize health care in Georgia and beyond through education, discovery, and service.
2020-2021 SEMINARS OPEN FACULTY POSITIONS DNRM FACILITIES Medical College of Georgia CORE FACILITIES
Chronic stress that changes the function of a tiny group of neurons known to be important to energy homeostasis in the body as well prompting us to pick up a fork when we are hungry may contribute to depression.
High doses of vitamin C under study for treating COVID-19 may benefit some populations, but investigators exploring its potential in aging say key factors in effectiveness include levels of the natural transporter needed to get the vitamin inside cells.
When the brain isn’t getting enough oxygen, estrogen produced by neurons in both males and females hyperactivates another brain cell type called astrocytes to step up their usual support and protect brain function.
A study of 181 patients at 16 sites across the country who test negative for two antibodies long known to cause muscle-weakening myasthenia gravis, found that about 15% test positive for one of two newly discovered antibodies that also attack the point of communication between nerves and muscle.
Neuroscience & Regenerative Medicine
Health Sciences Campus
Interdisciplinary Research Center
706-721-0700
1120 15th St.,
CA-3008, Augusta, GA 30912
1462 Laney Walker Blvd.
Augusta, GA 30912
706-446-1060
